2005
DOI: 10.1290/0507047.1
|View full text |Cite
|
Sign up to set email alerts
|

Protease Activity in Protein-Free Ns0 Myeloma Cell Cultures

Abstract: Zymography of concentrated conditioned medium (CM) from protein-free NS0 myeloma cell cultures showed that this cell line produced and released/secreted several proteases. Two caseinolytic activities at 45-50 and 90 kDa were identified as aspartic acid proteases, and at least two cathepsins of the papain-like cysteine protease family with molecular masses of 30-35 kDa were found by gelatin zymography. One of these cathepsins was identified as cathepsin L by using an enzyme assay exploiting the substrate Z-Phe-… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

1
6
0

Year Published

2009
2009
2019
2019

Publication Types

Select...
3
2

Relationship

1
4

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 30 publications
1
6
0
Order By: Relevance
“…In vitro studies show that tumor cells and osteoclasts, once activated by pro-inflammatory cytokines with bone resorption activity, secrete Cathepsin L, which participates in degrading bone matrix, thus allowing the homing of metastatic cells into the bone tissue [119-122, 127, 130-135]. These findings are consistent with recent in vitro observations, which demonstrate that the expression levels of Cathepsin L in tumor tissue are increased by proinflammatory cytokines with bone resorption activity such as IL-1b, IL-6 or TNF-a [67,68,[120][121][122][123][124][125]. Furthermore, Cathepsin L may indirectly promote bone degradation by triggering the activation of latent precursor forms of other proteolytic enzymes, such as MMPs, uPA and heparanase, which are known to foster metastatic cascade and bone remodeling processes [8,43,45,119,136].…”
Section: Cathepsin L and Cancer-related Bone Diseasessupporting
confidence: 78%
See 1 more Smart Citation
“…In vitro studies show that tumor cells and osteoclasts, once activated by pro-inflammatory cytokines with bone resorption activity, secrete Cathepsin L, which participates in degrading bone matrix, thus allowing the homing of metastatic cells into the bone tissue [119-122, 127, 130-135]. These findings are consistent with recent in vitro observations, which demonstrate that the expression levels of Cathepsin L in tumor tissue are increased by proinflammatory cytokines with bone resorption activity such as IL-1b, IL-6 or TNF-a [67,68,[120][121][122][123][124][125]. Furthermore, Cathepsin L may indirectly promote bone degradation by triggering the activation of latent precursor forms of other proteolytic enzymes, such as MMPs, uPA and heparanase, which are known to foster metastatic cascade and bone remodeling processes [8,43,45,119,136].…”
Section: Cathepsin L and Cancer-related Bone Diseasessupporting
confidence: 78%
“…In support of this hypothesis, experimental and clinical observations show that the expression levels of this endopeptidase are altered in some primary bone tumors [81,82,[119][120][121][122][123], in bone metastasis [81,82,119,120] and in tumors that preferentially metastasize to the bone [118,119,[125][126][127][128][129][130][131][132]. For instance, Park et al [81] report that Cathepsin L is expressed in 100% of metastatic bone tumors and only in 50% of primary human bone tumors.…”
Section: Cathepsin L and Cancer-related Bone Diseasesmentioning
confidence: 99%
“…Negative effects of ubiquitin on certain haematopoietic cells have been shown by Daino et al (2000). The presence of the cystein protease inhibitor cystatin C and the serine protease inhibitor SLPI in NS0 CM has been addressed in a previous publication together with the finding that NS0 cells also secrete several proteases (Spens and Häggström, 2005b). A group of serine proteases, active at culture pH, was shown to affect NS0 cell proliferation negatively.…”
Section: Discussionmentioning
confidence: 99%
“…There are several proteases that degrade gelatin (denatured collagen), which include the two matrix metalloproteases MMP-2 and MMP-9 [15]. Other enzymes are serine proteases like trypsin, plasmin and matriptase, as well as cysteine proteases such as cathepsin L [16,17,18,19]. In this protocol we focus on proteases that function around a neutral pH, but the protocol can be slightly changed for the detection of proteases with an optimal activity at slightly acidic pH (see Note 1).…”
Section: Introductionmentioning
confidence: 99%